Literature DB >> 15802729

Clomipramine and neuroleptic malignant syndrome: literature on adverse reactions to psychotropic drugs continues to confuse.

Geoffrey K Isbister, Nicholas A Buckley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15802729      PMCID： PMC555924          DOI： 10.1136/bmj.330.7494.790-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  The serotonin syndrome and its treatment.

Authors:  P K Gillman
Journal:  J Psychopharmacol       Date:  1999       Impact factor: 4.153

2.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Authors:  E J C Dunkley; G K Isbister; D Sibbritt; A H Dawson; I M Whyte
Journal:  QJM       Date:  2003-09

3.  Clomipramine induced neuroleptic malignant syndrome and pyrexia of unknown origin.

Authors:  Alison M Haddow; Dawn Harris; Martin Wilson; Hannah Logie
Journal:  BMJ       Date:  2004-12-04

4.  Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses.

Authors:  P J Neuvonen; S Pohjola-Sintonen; U Tacke; E Vuori
Journal:  Lancet       Date:  1993-12-04       Impact factor: 79.321

Review 5.  Neuroleptic malignant syndrome. Recognition, prevention and management.

Authors:  V R Velamoor
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606
  5 in total
  1 in total

1.  Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome?

Authors:  Kalliopi N Nikolaou; Rossetos Gournellis; Ioannis Michopoulos; Georgios Dervenoulas; Christos Christodoulou; Athanasios Douzenis
Journal:  Ann Gen Psychiatry       Date:  2015-11-14       Impact factor: 3.455
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.